Hormone replacement therapy in postmenopausal women appears to affect neither the risk of developing rheumatoid arthritis (RA) nor the severity of arthritis, researchers report in the March 15th issue of Arthritis & Rheumatism. Reuters Health Information
Kevin D. Deane, MD, comments on a study that examined the risk for cardiovascular disease in patients newly diagnosed with rheumatoid arthritis. Medscape Rheumatology
This review addresses how recently identified consistent osteoarthritis susceptibility genes influence both the onset of osteoarthritis, and its progression towards clinical outcomes. Current Opinion in Rheumatology
